As the Nasdaq suffered its steepest decline since 2022, some of the biggest losers were companies that sit at the intersection of Wall Street and Silicon Valley. "Our universe has modestly ...

After soaring following the election, Tesla (NASDAQ: TSLA) stock ran into a wall in February as a number of news items, macro challenges and CEO Elon Musk's involvement in the Department of ...

After soaring following the election, Tesla (NASDAQ: TSLA) stock ran into a wall in February as a number of news items, macro challenges and CEO Elon Musk's involvement in the Department of Government ...

After skyrocketing beginning last autumn, shares of quantum computing company IonQ (NYSE: IONQ) came back to earth this year. The stock is still up more than 120% over the past year as of this ...

IonQ's stock has been on a wild ride the past several months. The company is seeing strong growth and recently made two acquisitions. The stock is pricey, and it's a very speculative investment ...

The egg shortage and its effect on prices aren't doing the company any favors. It recently imposed surcharges on the many meals it makes with the protein, but these levies aren't universal. For ...

The S&P 500 tumbled 1.8% to resume its slide after a mini-recovery from the prior day clawed back some of its sharp drop over recent weeks. The Dow Jones Industrial Average dropped 427 points ...

NEW YORK (AP) — U.S. stocks tumbled Monday and wiped out even more of their gains since President Donald Trump ’s election in November, after he said that tariffs announced earlier on Canada ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Bitcoin has fallen below $90,000 for the first time this year, triggering a widespread sell-off in the crypto market while the U.S. remains asleep. At 4 a.m. ET, Bitcoin’s decline dragged the ...

An icon in the shape of a lightning bolt. Impact Link Tesla sales in Europe plunged in January, falling 45% compared with the same month last year, while overall sales of electric vehicles ...

Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19% in after-hours trading on Monday. The FDA removed semaglutide injections ...